Cancer Control Program

Program Leaders: Karen Glanz, PhD, MPH and Steven Joffe, MD, MPH

The Cancer Control Program is a transdisciplinary Program composed of members who focus on the identification of the genetic, behavioral, and health care determinants of cancer susceptibility and the development and implementation of strategies to lower risk and improve outcomes. The Program is directly concerned with improving cancer outcomes in the Abramson Cancer Center’s (ACC) catchment area and working inter-Programmatically with all Research Programs to apply advances in science to the health of populations. The members of the Program seek to improve population health across the cancer spectrum through advancing science in the areas of: 1) risk assessment; 2) survivorship; 3) communication and health behavior; and 4) health outcomes.

In the area of risk assessment, members have led multiple groundbreaking studies which established the basis for clinical management of women with BRCA1/2 mutations, identified risk loci associated with susceptibility to testicular germ cell tumors, and established genetic and genomic predictors of response to therapy in melanoma. In the area of survivorship, members have set clinical paradigms for cancer survivors through establishing care plans and demonstrating that exercise programs improve outcomes. In the area of communication and health behavior, members are national leaders in health messaging and behavioral economics, with innovative studies on the use of incentives for improving health behaviors. In the area of health outcomes, members lead critically important multidisciplinary studies on how research advances are translated into clinical practice and address health care disparities within the ACC catchment area.

The Program works closely with the Tobacco and Environmental Carcinogenesis Program to create a robust population science initiative with widespread inter- and intra-Programmatic collaborative efforts.

Cancer Control Program Membership